ProKidney Corp (NASDAQ:PROK) advances regenerative kidney disease research while the Nasdaq Composite highlights ongoing ...
Crinetics Pharmaceuticals explores rare endocrine treatments, PALSONIFY development, biotechnology operations, and healthcare innovation within the Nasdaq Composite market environment.
New! Sign up for our free email newsletter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results